Research Notes: Long term outcome of Merkel Cell Carcinoma after Avelumab exposure

Below is a working bibliography of trusted health, pharmacovigilance, and legal-analysis sources, compiled for open research.

Recommended deep-dive

Understanding Long term outcome of Merkel Cell Carcinoma after Avelumab exposure

Detailed background, context, and analysis on this topic, compiled for open research purposes.

World Health Organization (WHO)

Reference: World Health Organization (WHO)

Authoritative source for clinical, regulatory, and public-health background reading.

ClinicalTrials.gov

Reference: ClinicalTrials.gov

Authoritative source for clinical, regulatory, and public-health background reading.